Guru Ownership Trend
Guru Analysis for Denali Therapeutics Inc. (DNLI)
Denali Therapeutics Inc. (DNLI), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q1 2026, a total of 3 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $54.15 M.
Top institutional holders include Ken Fisher and Cliff Asness.
Institutional sentiment is currently Slightly Bearish. This is evidenced by a $30.17 M net outflow during the quarter.
Recent activity highlights Cliff Asness who increased their stake by 166.9%. Conversely, Ken Fisher reduced exposure by 5.9%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q1 2026)
Guru Consensus (Q1 2026)
FAQs for Denali Therapeutics Inc. (DNLI)
Major holders include Ken Fisher ($46.79 M), Cliff Asness ($1.97 M), Jefferies Group ($660,960). According to the latest reported data, 3 tracked investment managers collectively hold approximately 2.57 M shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $30.17 M, with 2 managers increasing positions and 4 managers reducing holdings.
During the most recent reporting period, 1 managers trimmed their positions, while 3 fully exited DNLI. The total reported sell value was $32.06 M.
Yes, 1 managers opened new positions in DNLI, and 1 increased their existing holdings. The total reported buy value was $1.89 M.